Oligometastatic Clinical Trials in Barcelona
3 recruitingBarcelona, Spain
Showing 1–3 of 3 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled147 locationsNCT05939414
Recruiting
Phase 3
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
Oligometastatic Squamous Cell Carcinoma of the Head and Neck
European Organisation for Research and Treatment of Cancer - EORTC200 enrolled30 locationsNCT05815927
Recruiting
Phase 2
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Ovarian CancerOligometastatic DiseaseSerous Ovarian Tumor
MedSIR30 enrolled14 locationsNCT06180356